These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy. Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740 [TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy for glioblastoma. Yamamoto T; Nakai K; Matsumura A Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207 [TBL] [Abstract][Full Text] [Related]
5. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro. Pöller F; Sauerwein W Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565 [TBL] [Abstract][Full Text] [Related]
6. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy. Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904 [TBL] [Abstract][Full Text] [Related]
8. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412 [TBL] [Abstract][Full Text] [Related]
9. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy. Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210 [TBL] [Abstract][Full Text] [Related]
10. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011). Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787 [TBL] [Abstract][Full Text] [Related]
11. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI; Chung HP; Liu HM; Chi CW; Lui WY Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [TBL] [Abstract][Full Text] [Related]
12. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer. Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233 [TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of high grade glioma: use of fast neutrons, therapy and enhancement by neutron capture]. Paquis P; Pignol JP; Breteau N Neurochirurgie; 2000 Feb; 46(1):23-33. PubMed ID: 10790640 [TBL] [Abstract][Full Text] [Related]
14. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618 [TBL] [Abstract][Full Text] [Related]
15. The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model. Coderre JA; Morris GM; Kalef-Ezra J; Micca PL; Ma R; Youngs K; Gordon CR Radiat Res; 1999 Aug; 152(2):113-8. PubMed ID: 10409319 [TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors. Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355 [TBL] [Abstract][Full Text] [Related]
18. Comparative assessment of single-dose and fractionated boron neutron capture therapy. Coderre JA; Morris GM; Micca PL; Fisher CD; Ross GA Radiat Res; 1995 Dec; 144(3):310-7. PubMed ID: 7494875 [TBL] [Abstract][Full Text] [Related]
19. Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy. Smith DR; Chandra S; Coderre JA; Morrison GH Cancer Res; 1996 Oct; 56(19):4302-6. PubMed ID: 8813111 [TBL] [Abstract][Full Text] [Related]
20. RBE in fast neutron therapy and in boron neutron capture therapy. A useful concept or a misuse? Wambersie A; Menzel HG Strahlenther Onkol; 1993 Jan; 169(1):57-64. PubMed ID: 8434341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]